Evaluation and Follow-up of People With Tick-borne Diseases
Reason given: No recruitment
Key facts
- Where
- Baltimore, United StatesSee the site
Where in United States
- University of Maryland Baltimore, Department of MedicineBaltimore, United StatesNo longer taking part
Trial details
- Who runs it
- National Institute of Allergy and Infectious Diseases (NIAID)
- Trial code
- NCT04318925
- Record updated
- 18 November 2023
- Original description
Background:Read full original descriptionShow less
Evaluation and Follow-up of Patients With Tick-borne Diseases
Background:
Lyme disease is the most common tick-borne disease in the United States, but other diseases transmitted by ticks have also been on the rise in recent years. Early symptoms of a tickborne disease include fever, headache, fatigue and possible rash. Researchers want to collect information and samples from people with Lyme disease and other tick-borne illnesses to better understand and diagnose these diseases.
Objective:
To evaluate and follow people with tick-borne diseases to help researchers learn more about these infections.
Eligibility:
People ages 18 and older who have or are suspected of having a tick-borne infection.
Design:
Participants will have an initial visit, and visits about 1, 6, and 12 months later. The visits can include a physical exam, blood tests, collection of blood, urine and saliva samples for research, and filling out health-related questionnaires. Participants who have the rash of Lyme disease may be invited to have up to 3 skin punch biopsies of the rash for research.
Exclusion: Post-treatment Lyme disease syndrome; Any other condition or history of unacceptably poor compliance that, in the opinion of the investigator, would make the patient unsuitable for enrollment or could interfere with the patient participating in and completing the study; Women who report they are pregnant.
INCLUSION CRITERIA:; Clinical diagnosis of suspected, confirmed, or probable LB or other TBD per CDC case definitions; Has not received antibiotic therapy for tick-borne disease for more than 2 weeks; Age >=18 years; Able to provide informed consent; Subjects must maintain a private physician for non-protocol related medical complaints and for emergency medical treatment required for these or other disorders.